EUVIMEDEUVIMED entdecken
Open Access

Capecitabine-Induced Hand-Foot Syndrome With Genital Involvement

Yue Feng, Christina Baroody, Salwan Al Mutar

Journal of the Advanced Practitioner in Oncology · 26.06.2026 · 17 (7)

DOI: 10.6004/jadpro.2026.17.7.21 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Advanced Practitioner in Oncology, online erschienen am 26.06.2026. Verfasst von Yue Feng und 2 weiteren Autor:innen. Beteiligte Einrichtung: From Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, Texas. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Palmar-plantar erythrodysesthesia, also known as hand-foot syndrome (HFS), is a common dermatologic toxicity of capecitabine. In this report, the case of a 59-year-old man with metastatic pancreatic ductal adenocarcinoma who developed grade 2 HFS with rare genital involvement is described. This case underscores the importance of recognizing atypical genital involvement in HFS to support timely management.

Autor:innen und Institutionen

  • From Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, Texas.

Zitieren

APA

Feng, Y., Baroody, C., & Al Mutar, S. (2026). Capecitabine-Induced Hand-Foot Syndrome With Genital Involvement. Journal of the Advanced Practitioner in Oncology, 17(7). https://doi.org/10.6004/jadpro.2026.17.7.21

Vancouver

Feng Y, Baroody C, Al Mutar S. Capecitabine-Induced Hand-Foot Syndrome With Genital Involvement. Journal of the Advanced Practitioner in Oncology. 2026;17(7). doi:10.6004/jadpro.2026.17.7.21

BibTeX
@article{Feng2026,
  author = {Feng, Yue and Baroody, Christina and Al Mutar, Salwan},
  title = {Capecitabine-Induced Hand-Foot Syndrome With Genital Involvement},
  journal = {Journal of the Advanced Practitioner in Oncology},
  year = {2026},
  volume = {17},
  number = {7},
  doi = {10.6004/jadpro.2026.17.7.21}
}
Kostenlos starten →